ANDA 76377, held by Heritage Pharma Avet. Terbinafine Hydrochloride.
As of Nov 22, 2026, ANDA 76377 (Terbinafine Hydrochloride), held by Heritage Pharma Avet, was first approved by FDA on Jul 2, 2007, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 2, 2007 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Terbinafine HydrochlorideEQ 250MG BASE · tablet;oral | Terbinafine Hydrochloride | Discontinued |
| Aug 31, 2021 | Supplement 5Labeling · Standard review | Approved | None posted |
| Aug 31, 2021 | Supplement 6Labeling · Standard review | Approved | None posted |
| Feb 8, 2011 | Supplement 3Labeling | Approved | None posted |
| Jul 2, 2007 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters